News & Announcements

Kidney injury detection

FNIH Biomarkers Consortium and Critical Path Institute achieve the first ever qualification of a clinical safety biomarker by the U.S. Food and Drug Administration.

Andrew Lee

The FNIH will bestow this year’s Partnership Award to Andrew, President & CEO of Driven to Cure, Inc., for his unwavering commitment to advancing biomedical research on rare kidney cancers.

Dr. Michael Fox

Michael Fox, M.D., Ph.D., developed innovative techniques to map brain connectivity that can be translated into new treatments for neurological diseases.


Dr. Maria Freire

Learn more about Dr. Freire in this “Women in Business” Q&A featured in the Huffington Post.

Stevie Award

Learn how the AMP RA/Lupus project is helping patients with rheumatoid arthritis and lupus.

 FNIH Rated #1 Charity

The FNIH is delighted to once again earn the highest, 4-star rating from Charity Navigator.


Front Page: